PharmAware Blog » Print » Avandia adviser amy be probed for possible conflict of interests

Avandia adviser amy be probed for possible conflict of interests

Posted By admin On 16/08/2010 @ 05:08 pm In International News | No Comments

The US FDA is looking to investigate a member of the panel that recently recommended restrictions on rosiglitazone for conflict of interest. Dr Capuzzi was one of the panel members who voted to keep rosiglitazone on the market. However, several news organisations have reported that Dr Cauzzi has been a member of GSKs speakers’ bureau.

BMJ 2010; 241:c4083

Article printed from PharmAware Blog: http://pharmawareblog.co.uk

URL to article: http://pharmawareblog.co.uk/2010/08/16/avandia-adviser-amy-be-probed-for-possible-conflict-of-interests/

Click here to print.